Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo
Authors
Keywords
T cells, Spleen, B cells, Immune response, Cytotoxic T cells, Plasmid construction, Flow cytometry, Antigen-presenting cells
Journal
PLoS One
Volume 9, Issue 7, Pages e101644
Publisher
Public Library of Science (PLoS)
Online
2014-07-25
DOI
10.1371/journal.pone.0101644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
- (2014) F. Amirache et al. BLOOD
- Specific gene delivery to liver sinusoidal and artery endothelial cells
- (2013) T. Abel et al. BLOOD
- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- Insertional Mutagenesis by Retroviral Vectors: Current Concepts and Methods of Analysis
- (2013) Sean Knight et al. CURRENT GENE THERAPY
- CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
- (2013) Sabrina Kneissl et al. PLoS One
- LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
- (2013) D. Finkelshtein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The physiological role of DC-SIGN: A tale of mice and men
- (2013) Juan J. Garcia-Vallejo et al. TRENDS IN IMMUNOLOGY
- Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
- (2012) C Goyvaerts et al. GENE THERAPY
- MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAV
- (2012) Muriel Sudres et al. MOLECULAR THERAPY
- HIV-derived vectors for therapy and vaccination against HIV
- (2012) F. Di Nunzio et al. VACCINE
- Lentiviral Vectors Targeted to MHC II Are Effective in Immunization
- (2011) Alexander Ageichik et al. HUMAN GENE THERAPY
- Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
- (2010) Otto-Wilhelm Merten et al. HUMAN GENE THERAPY
- Immunization delivered by lentiviral vectors for cancer and infectious diseases
- (2010) Biliang Hu et al. IMMUNOLOGICAL REVIEWS
- HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
- (2010) K. Breckpot et al. JOURNAL OF VIROLOGY
- Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors
- (2010) Brigitte Anliker et al. NATURE METHODS
- Single-Chain Antibodies That Target Lentiviral Vectors to MHC Class II on Antigen-Presenting Cells
- (2009) Francesca Gennari et al. HUMAN GENE THERAPY
- Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose
- (2009) Margarida Saraiva et al. IMMUNITY
- Lentiviral vectors with measles virus glycoproteins – dream team for gene transfer?
- (2009) Christian J. Buchholz et al. TRENDS IN BIOTECHNOLOGY
- Targeted Cell Entry of Lentiviral Vectors
- (2008) Sabrina Funke et al. MOLECULAR THERAPY
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started